Groundwork laid for first Kids' shield against painful mosquito virus
NCT ID NCT07133178
Summary
This study aimed to test a vaccine designed to protect children from the chikungunya virus, a painful mosquito-borne illness. It planned to enroll at least 3,000 healthy children aged 1 to 11 years to receive either the experimental vaccine or a comparator vaccine. The main goal was to see if the vaccine was safe and triggered a strong immune response, but the trial was withdrawn before any participants were enrolled.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHIKUNGUNYA VIRUS INFECTION are added.
By submitting, you agree to our Terms of use
Conditions
Explore the condition pages connected to this study.